Global /Japan /Healthcare /Medical Care Facilities /4694
chevron_leftBack
BML, Inc. logo

BML, Inc.

4694
TSE: 4694 Delayed
3,815JPY -0.3%
23.84 USD
As of 6 June 2026, BML, Inc. has a market cap of $895.94M USD, ranking #11354 globally and #818 in Japan. It ranks #1026 in the Healthcare sector, and #122 in the Medical Care Facilities industry.
Global Rank
11354
Country Rank
818
Sector Rank
1026
Industry Rank
122
Key Stats
Market Cap
$895.94MUSD
143.37B JPY
Enterprise Value
$521.36MUSD
83.43B JPY
Revenue (TTM)
$931.64MUSD
149.09B JPY
EBITDA (TTM)
$118.11MUSD
18.9B JPY
Net Income (TTM)
$47.24MUSD
7.56B JPY
PE Ratio
19.5
Forward PE
17.7
PS Ratio
1.0
PB Ratio
1.1
EV/EBITDA
4.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Kensuke Kondo open_in_new
Employees
4,558
Founded
1955
Website
bml.co.jp open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.3% 0.9% -8.3% -2.2% 6.1% 29%

News

Loading...

Markets

Exchange Ticker Price
Tokyo Stock Exchange
MIC: XTKS
PRIMARY
4694
株式会社ビー・エム・エル
ISIN: JP3799700004
Shares Out.:
37.484M1 Shares Float: 18.219M2
TV:
SA:
YF:
GF:
BA:
MS:
3,815 JPY
OTC Markets
MIC: OTCM
BMLKF
株式会社ビー・エム・エル
ISIN: JP3799700004
Shares Out.:
39.007M1 Shares Float: 20.267M2
TV:
SA:
YF:
GF:
BA:
MS:
24.96 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About BML, Inc.

BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing. It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds. In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.

Similar Companies

Industry: Medical Care Facilities (Japan)
Name
Market Cap diff.
PE
$1.08B
172.62B JPY
20%
31.6
6062
$263.65M
42.19B JPY
-71%
12.8
$238.92M
38.23B JPY
-73%
11.3
$211.05M
33.77B JPY
-76%
41.8
$186.75M
29.88B JPY
-79%
17.8
$135.51M
21.69B JPY
-85%
-
Industry: Medical Care Facilities (Global)
Name
Market Cap diff.
PE
$232.18B
852.82B AED
26K%
44.1
$96.73B
11K%
14.9
$26.68B
22.97B EUR
3K%
15.0
$25.58B
22.02B EUR
3K%
24.9
$22.48B
84.42B SAR
2K%
35.2
$21.13B
2K%
24.6
chevron_leftBack